Catalyst Wire Dossier Catalyst Wire Dossier

Lu 31-130

· H. Lundbeck A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lu 31-130, covering 2016-11-08 to 2016-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Lu 31-130 in Patients With Schizophrenia [Phase 2]

See pricing